NACDS Backs Trump Administration’s Biosimilar Action, Also Calls for PBM Reform to Lower Drug Costs
Pharmacists ready to help Americans save more as FDA streamlines biosimilar approvals and advances interchangeability; NACDS urges Congress to finish its job on PBM reform.
